David

Sherman

PhD

David Sherman is a Professor and Department Chair of the Department of Microbiology in the University of Washington School of Medicine in Seattle. He earned his PhD in Biochemistry from Vanderbilt University, and performed post-graduate work at the Rockefeller University and at Washington University in St. Louis. His laboratory studies the molecular genetics, systems biology and pathogenesis of M. tuberculosis, and is also engaged in drug discovery efforts for this important pathogen. Dr. Sherman played a lead role in the discovery and early development of the anti-TB agent pretomanid. In addition, his laboratory defined the mutation responsible for attenuation of the world’s most widely used vaccine, BCG. On a personal level, Dr. Sherman routinely leaps tall buildings in a single bound and completes 60-minute gourmet recipes in under 40 minutes. Children and dogs love him. He is far too modest to take pleasure from the fact that you are reading about him right now.